AFREZZA: FAST-ACTING INHALED INSULIN

被引：0
|
作者：
Aschenbrenner, Diane S. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA
来源：
AMERICAN JOURNAL OF NURSING | 2014年 / 114卷 / 10期
关键词：
D O I：
10.1097/01.NAJ.0000454844.50727.76
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Afrezza (insulin human) is a newly approved fast-acting inhaled insulin. It can be used in treating type 1 diabetes when added to a long-acting insulin; in studies, patients with type 2 diabetes used it in combination with oral antidiabetic therapy. Afrezza will be available in 2015. Afrezza is taken before meals using a small, specially designed inhaler. Patients should be carefully assessed for lung disease prior to starting Afrezza therapy. Chronic obstructive pulmonary disease and asthma are contraindications to use. Lung function can deteriorate after therapy begins.
引用
收藏
页码：22 / 23
页数：2
相关论文
共 50 条
  • [21] Use of fast-acting insulin aspart in insulin pump therapy in clinical practice
    Evans, Mark
    Ceriello, Antonio
    Danne, Thomas
    De Block, Christophe
    DeVries, J. Hans
    Lind, Marcus
    Mathieu, Chantal
    Norgaard, Kirsten
    Renard, Eric
    Wilmot, Emma G.
    DIABETES OBESITY & METABOLISM, 2019, 21 (09): : 2039 - 2047
  • [22] FAST-ACTING HUMAN INSULIN ANALOGS - A PROMISING INNOVATION IN DIABETES CARE
    BETZ, JL
    DIABETES EDUCATOR, 1995, 21 (03): : 195 - &
  • [23] Modeling Subcutaneous Absorption of Fast-Acting Insulin in Type 1 Diabetes
    Schiavon, Michele
    Dalla Man, Chiara
    Cobelli, Claudio
    IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, 2018, 65 (09) : 2079 - 2086
  • [24] A FAST-ACTING ELECTROLYTIC SWITCH
    BUTLER, JF
    PROCEEDINGS OF THE IEEE, 1963, 51 (01) : 241 - &
  • [25] Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide
    Kildegaard, Jonas
    Buckley, Stephen T.
    Nielsen, Rasmus H.
    Povlsen, Gro K.
    Seested, Torben
    Ribel, Ulla
    Olsen, Helle B.
    Ludvigsen, Svend
    Jeppesen, Claus B.
    Refsgaard, Hanne H. F.
    Bendtsen, Kristian M.
    Kristensen, Niels R.
    Hostrup, Susanne
    Sturis, Jeppe
    PHARMACEUTICAL RESEARCH, 2019, 36 (03)
  • [26] Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide
    Jonas Kildegaard
    Stephen T. Buckley
    Rasmus H. Nielsen
    Gro K. Povlsen
    Torben Seested
    Ulla Ribel
    Helle B. Olsen
    Svend Ludvigsen
    Claus B. Jeppesen
    Hanne H. F. Refsgaard
    Kristian M. Bendtsen
    Niels R. Kristensen
    Susanne Hostrup
    Jeppe Sturis
    Pharmaceutical Research, 2019, 36
  • [27] FAST-ACTING GAS VALVE
    WETSTONE, DM
    REVIEW OF SCIENTIFIC INSTRUMENTS, 1961, 32 (11): : 1209 - &
  • [28] Amphiphilic Polyacrylamide Excipients Lead to a Record-Breaking Fast-Acting Insulin
    Angsantikul, Pavimol
    Mitragotri, Samir
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2020, 41 (10) : 681 - 684
  • [29] Fast-Acting Insulin Aspart Use with the MiniMedTM 670G System
    Hsu, Liana
    Buckingham, Bruce
    Basina, Marina
    Ekhlaspour, Laya
    von Eyben, Rie
    Wang, Justin
    Lal, Rayhan A.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 (01) : 1 - 7
  • [30] FAST-ACTING INSULIN ASPART AT HIGH DOSES IN INDIVIDUALS WITH TYPE 2 DIABETES
    Bowering, K.
    Harvey, J.
    Kolaczynski, J.
    Snyder, J.
    Bode, B.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A133 - A133
12345